25 XP   0   0   10

MEI Pharma Inc
Buy, Hold or Sell?

Let's analyse MEI Pharma Inc together

PenkeI guess you are interested in MEI Pharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of MEI Pharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about MEI Pharma Inc

I send you an email if I find something interesting about MEI Pharma Inc.

Quick analysis of MEI Pharma Inc (30 sec.)










What can you expect buying and holding a share of MEI Pharma Inc? (30 sec.)

How much money do you get?

How much money do you get?
$1.75
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$8.93
Expected worth in 1 year
$10.60
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$3.42
Return On Investment
102.6%

For what price can you sell your share?

Current Price per Share
$3.33
Expected price per share
$3.1071428571429 - $3.55
How sure are you?
50%

1. Valuation of MEI Pharma Inc (5 min.)




Live pricePrice per Share (EOD)

$3.33

Intrinsic Value Per Share

$-158.71 - $-44.98

Total Value Per Share

$-149.78 - $-36.05

2. Growth of MEI Pharma Inc (5 min.)




Is MEI Pharma Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$59.4m$51.4m-$1.5m-3.0%

How much money is MEI Pharma Inc making?

Current yearPrevious yearGrowGrow %
Making money$5.1m-$12.1m$17.3m334.4%
Net Profit Margin-211.9%-155.8%--

How much money comes from the company's main activities?

3. Financial Health of MEI Pharma Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#451 / 1010

Most Revenue
#239 / 1010

Most Profit
#109 / 1010

Most Efficient
#639 / 1010

What can you expect buying and holding a share of MEI Pharma Inc? (5 min.)

Welcome investor! MEI Pharma Inc's management wants to use your money to grow the business. In return you get a share of MEI Pharma Inc.

What can you expect buying and holding a share of MEI Pharma Inc?

First you should know what it really means to hold a share of MEI Pharma Inc. And how you can make/lose money.

Speculation

The Price per Share of MEI Pharma Inc is $3.3323. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of MEI Pharma Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in MEI Pharma Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.93. Based on the TTM, the Book Value Change Per Share is $0.42 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.44 per quarter.
Based on historical numbers we can estimate the returns while holding a share of MEI Pharma Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.66-49.8%0.7422.3%-0.86-25.8%-0.99-29.6%-0.90-27.1%
Usd Book Value Change Per Share-3.28-98.5%0.4212.5%-1.08-32.5%0.051.4%0.000.1%
Usd Dividend Per Share1.7552.5%0.4413.1%0.000.0%0.092.6%0.041.3%
Usd Total Gains Per Share-1.53-46.0%0.8525.6%-1.08-32.5%0.134.0%0.051.4%
Usd Price Per Share5.80-4.90-0.46-2.72-2.93-
Price to Earnings Ratio-0.87--0.45--0.50--0.49--0.66-
Price-to-Total Gains Ratio-3.78--1.89-0.00--1.24-21.14-
Price to Book Ratio0.65-0.76-0.29-0.42-0.43-
Price-to-Total Gains Ratio-3.78--1.89-0.00--1.24-21.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.3323
Number of shares300
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.440.09
Usd Book Value Change Per Share0.420.05
Usd Total Gains Per Share0.850.13
Gains per Quarter (300 shares)256.3539.80
Gains per Year (300 shares)1,025.41159.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1525500101510554149
2105010012040210108308
3157515013065315163467
4210020024090420217626
5262525025115525271785
6315030036140630325944
73675350371657353791103
84200400381908404331262
94725450492159454881421
10525050041024010505421580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%3.017.00.015.0%5.035.00.012.5%5.081.01.05.7%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%8.012.00.040.0%14.026.00.035.0%25.056.06.028.7%
Dividend per Share1.00.03.025.0%2.00.010.016.7%2.00.018.010.0%2.00.038.05.0%6.00.081.06.9%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%8.012.00.040.0%14.026.00.035.0%25.056.06.028.7%

Fundamentals of MEI Pharma Inc

About MEI Pharma Inc

MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor for the treatment of patients with relapsed/refractory follicular lymphoma; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase I clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex which has completed Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer. MEI Pharma, Inc. has a license agreement with Presage Biosciences, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-04-11 14:27:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of MEI Pharma Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit MEI Pharma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare MEI Pharma Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MEI Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-211.9%+211.9%
TTM-211.9%YOY-155.8%-56.2%
TTM-211.9%5Y-346.3%+134.4%
5Y-346.3%10Y-384.9%+38.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM-211.9%-216.8%+4.9%
YOY-155.8%-288.3%+132.5%
5Y-346.3%-449.1%+102.8%
10Y-384.9%-605.5%+220.6%
1.1.2. Return on Assets

Shows how efficient MEI Pharma Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare MEI Pharma Inc to the Biotechnology industry mean.
  • -14.1% Return on Assets means that MEI Pharma Inc generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MEI Pharma Inc:

  • The MRQ is -14.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 5.6%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ-14.1%TTM5.6%-19.7%
TTM5.6%YOY-6.5%+12.1%
TTM5.6%5Y-4.6%+10.3%
5Y-4.6%10Y-7.0%+2.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.1%-13.3%-0.8%
TTM5.6%-12.8%+18.4%
YOY-6.5%-11.7%+5.2%
5Y-4.6%-13.9%+9.3%
10Y-7.0%-15.7%+8.7%
1.1.3. Return on Equity

Shows how efficient MEI Pharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare MEI Pharma Inc to the Biotechnology industry mean.
  • -18.6% Return on Equity means MEI Pharma Inc generated $-0.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MEI Pharma Inc:

  • The MRQ is -18.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.6%TTM-8.1%-10.5%
TTM-8.1%YOY-23.4%+15.3%
TTM-8.1%5Y-18.7%+10.6%
5Y-18.7%10Y-15.3%-3.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.6%-16.9%-1.7%
TTM-8.1%-16.1%+8.0%
YOY-23.4%-15.1%-8.3%
5Y-18.7%-19.3%+0.6%
10Y-15.3%-20.2%+4.9%

1.2. Operating Efficiency of MEI Pharma Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient MEI Pharma Inc is operating .

  • Measures how much profit MEI Pharma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare MEI Pharma Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MEI Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-238.5%+238.5%
TTM-238.5%YOY-147.3%-91.2%
TTM-238.5%5Y-506.8%+268.3%
5Y-506.8%10Y-422.8%-84.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM-238.5%-232.5%-6.0%
YOY-147.3%-298.2%+150.9%
5Y-506.8%-492.1%-14.7%
10Y-422.8%-632.4%+209.6%
1.2.2. Operating Ratio

Measures how efficient MEI Pharma Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of MEI Pharma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.236-3.236
TTM3.236YOY2.338+0.898
TTM3.2365Y5.274-2.038
5Y5.27410Y4.549+0.725
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM3.2363.310-0.074
YOY2.3383.890-1.552
5Y5.2745.739-0.465
10Y4.5497.876-3.327

1.3. Liquidity of MEI Pharma Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if MEI Pharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.23 means the company has $8.23 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of MEI Pharma Inc:

  • The MRQ is 8.232. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.236. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.232TTM7.236+0.996
TTM7.236YOY6.685+0.551
TTM7.2365Y6.946+0.290
5Y6.94610Y9.443-2.497
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.2323.890+4.342
TTM7.2364.173+3.063
YOY6.6855.344+1.341
5Y6.9466.126+0.820
10Y9.4436.448+2.995
1.3.2. Quick Ratio

Measures if MEI Pharma Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare MEI Pharma Inc to the Biotechnology industry mean.
  • A Quick Ratio of 14.16 means the company can pay off $14.16 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MEI Pharma Inc:

  • The MRQ is 14.156. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 12.835. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ14.156TTM12.835+1.321
TTM12.835YOY12.139+0.696
TTM12.8355Y12.615+0.220
5Y12.61510Y16.628-4.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.1563.514+10.642
TTM12.8353.998+8.837
YOY12.1395.380+6.759
5Y12.6156.105+6.510
10Y16.6286.404+10.224

1.4. Solvency of MEI Pharma Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of MEI Pharma Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare MEI Pharma Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.24 means that MEI Pharma Inc assets are financed with 24.3% credit (debt) and the remaining percentage (100% - 24.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MEI Pharma Inc:

  • The MRQ is 0.243. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.495. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.243TTM0.495-0.252
TTM0.495YOY0.700-0.205
TTM0.4955Y0.572-0.077
5Y0.57210Y0.367+0.204
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2430.339-0.096
TTM0.4950.336+0.159
YOY0.7000.271+0.429
5Y0.5720.366+0.206
10Y0.3670.389-0.022
1.4.2. Debt to Equity Ratio

Measures if MEI Pharma Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare MEI Pharma Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 32.0% means that company has $0.32 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MEI Pharma Inc:

  • The MRQ is 0.320. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.844. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ0.320TTM1.844-1.524
TTM1.844YOY2.424-0.580
TTM1.8445Y1.893-0.049
5Y1.89310Y1.078+0.815
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3200.388-0.068
TTM1.8440.402+1.442
YOY2.4240.335+2.089
5Y1.8930.426+1.467
10Y1.0780.461+0.617

2. Market Valuation of MEI Pharma Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings MEI Pharma Inc generates.

  • Above 15 is considered overpriced but always compare MEI Pharma Inc to the Biotechnology industry mean.
  • A PE ratio of -0.87 means the investor is paying $-0.87 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MEI Pharma Inc:

  • The EOD is -0.502. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.873. Based on the earnings, the company is expensive. -2
  • The TTM is -0.446. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.502MRQ-0.873+0.372
MRQ-0.873TTM-0.446-0.427
TTM-0.446YOY-0.501+0.055
TTM-0.4465Y-0.494+0.049
5Y-0.49410Y-0.660+0.166
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.502-2.264+1.762
MRQ-0.873-2.629+1.756
TTM-0.446-2.680+2.234
YOY-0.501-4.145+3.644
5Y-0.494-6.257+5.763
10Y-0.660-6.254+5.594
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MEI Pharma Inc:

  • The EOD is -0.502. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.873. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.627. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.502MRQ-0.873+0.372
MRQ-0.873TTM-0.627-0.246
TTM-0.627YOY-0.282-0.345
TTM-0.6275Y-0.333-0.294
5Y-0.33310Y-0.512+0.179
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.502-2.973+2.471
MRQ-0.873-3.333+2.460
TTM-0.627-3.553+2.926
YOY-0.282-5.605+5.323
5Y-0.333-8.376+8.043
10Y-0.512-8.865+8.353
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of MEI Pharma Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.65 means the investor is paying $0.65 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of MEI Pharma Inc:

  • The EOD is 0.373. Based on the equity, the company is cheap. +2
  • The MRQ is 0.650. Based on the equity, the company is cheap. +2
  • The TTM is 0.762. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.373MRQ0.650-0.276
MRQ0.650TTM0.762-0.113
TTM0.762YOY0.295+0.467
TTM0.7625Y0.416+0.346
5Y0.41610Y0.429-0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3731.896-1.523
MRQ0.6502.115-1.465
TTM0.7622.093-1.331
YOY0.2952.884-2.589
5Y0.4163.542-3.126
10Y0.4293.916-3.487
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of MEI Pharma Inc.

3.1. Institutions holding MEI Pharma Inc

Institutions are holding 47.596% of the shares of MEI Pharma Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Anson Funds Management LP16.40720.7839109318822900026.4989
2023-12-31Cable Car Capital LLC9.17683.68226114406114400
2023-12-31Vanguard Group Inc5.85040.000138980762601.6321
2023-09-30TANG CAPITAL MANAGEMENT LLC4.89410.3226326084-35000-9.693
2023-12-31Acadian Asset Management LLC3.38280.0051225391-5154-2.2356
2023-12-31Renaissance Technologies Corp2.26470.001415089266464.6074
2023-09-30LAURION CAPITAL MANAGEMENT LP1.93380.005512884500
2023-12-31BlackRock Inc1.2505083318-211-0.2526
2023-12-31Carlson Capital LP1.11060.034374000-51000-40.8
2023-12-31Geode Capital Management, LLC0.774705161616283.2568
2023-12-31Macquarie Group Ltd0.45020.00022999900
2023-12-31Bridgeway Capital Management, LLC0.40330.003326869850046.2736
2023-12-31Northern Trust Corp0.371902478014230134.8815
2023-12-31State Street Corporation0.267501782100
2023-12-31Susquehanna International Group, LLP0.202013459134590
2023-12-31Royal Bank of Canada0.17870119061181913585.0575
2023-12-31Dimensional Fund Advisors, Inc.0.164301094600
2023-12-31Morgan Stanley - Brokerage Accounts0.08810586800
2023-12-31Group One Trading, LP0.08490.00015658-52409-90.2561
2023-12-31Newbridge Financial Services Group, Inc.0.030.0057199900
Total 49.28654.84443283886+759208+23.1%

3.2. Funds holding MEI Pharma Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv3.01830.000120110600
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.1940.00037955400
2023-12-31Vanguard Explorer Inv0.92480.00176162100
2023-12-31Vanguard VIF Small Co Gr0.55470.01423696000
2024-02-29Fidelity Extended Market Index0.46390.000330910-150-0.4829
2024-02-29Delaware Healthcare I0.45030.0163000000
2023-12-31Bridgeway Ultra-Small Company0.40330.179826869850046.2736
2024-03-28iShares Micro-Cap ETF0.21490.00621431800
2023-12-31RBC Microcap Value I0.17560.059611700117000
2023-09-30BlackRock Extended Mkt Composite0.16320.00051087500
2024-03-31BlackRock Extended Equity Market K0.14240.0003949130.0316
2024-02-29Fidelity Series Total Market Index0.11080.0001738100
2023-07-31Granate BCI Flexible C0.10510.2981700000
2024-02-29Fidelity Total Market Index0.10070670800
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.08490.0005565500
2024-02-29DFA US Small Cap I0.08370.0002557600
2024-02-29Schwab Total Stock Market Index0.07240.0001482200
2024-02-29Vanguard Balanced Index Inv0.07030468600
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.06820.0005454290.1985
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06510.0004433500
Total 8.46660.5789564109+20062+3.6%

3.3. Insider Transactions

Insiders are holding 0.55% of the shares of MEI Pharma Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-22Anson Funds Management LpBUY480606.85
2023-09-20Anson Funds Management LpBUY1200006.01

4. Summary

4.1. Key Performance Indicators

The key performance indicators of MEI Pharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.2830.417-887%-1.084-67%0.045-7371%0.003-115257%
Book Value Per Share--8.9287.498+19%5.332+67%7.926+13%7.680+16%
Current Ratio--8.2327.236+14%6.685+23%6.946+19%9.443-13%
Debt To Asset Ratio--0.2430.495-51%0.700-65%0.572-58%0.367-34%
Debt To Equity Ratio--0.3201.844-83%2.424-87%1.893-83%1.078-70%
Dividend Per Share--1.7500.437+300%0.000+1313037%0.088+1899%0.044+3899%
Eps---1.6600.745-323%-0.861-48%-0.988-41%-0.904-46%
Free Cash Flow Per Share---1.660-1.986+20%-1.721+4%-1.005-39%-0.821-51%
Free Cash Flow To Equity Per Share---3.410-2.424-29%-1.721-50%-0.136-96%0.386-984%
Gross Profit Margin--1.0081.002+1%1.000+1%1.000+1%1.000+1%
Intrinsic Value_10Y_max---44.978--------
Intrinsic Value_10Y_min---158.710--------
Intrinsic Value_1Y_max---3.465--------
Intrinsic Value_1Y_min---8.657--------
Intrinsic Value_3Y_max---11.204--------
Intrinsic Value_3Y_min---32.442--------
Intrinsic Value_5Y_max---19.902--------
Intrinsic Value_5Y_min---63.092--------
Market Cap22202648.378-74%38645400.00032680182.675+18%19011400.864+103%21312047.128+81%21130039.484+83%
Net Profit Margin----2.1190%-1.5580%-3.4630%-3.8490%
Operating Margin----2.3850%-1.4730%-5.0680%-4.2280%
Operating Ratio---3.236-100%2.338-100%5.274-100%4.549-100%
Pb Ratio0.373-74%0.6500.762-15%0.295+120%0.416+56%0.429+51%
Pe Ratio-0.502+43%-0.873-0.446-49%-0.501-43%-0.494-43%-0.660-24%
Price Per Share3.332-74%5.8004.905+18%0.459+1162%2.720+113%2.932+98%
Price To Free Cash Flow Ratio-0.502+43%-0.873-0.627-28%-0.282-68%-0.333-62%-0.512-41%
Price To Total Gains Ratio-2.174+43%-3.784-1.894-50%0.001-326983%-1.245-67%21.144-118%
Quick Ratio--14.15612.835+10%12.139+17%12.615+12%16.628-15%
Return On Assets---0.1410.056-350%-0.065-54%-0.046-67%-0.070-50%
Return On Equity---0.186-0.081-57%-0.234+26%-0.187+0%-0.153-17%
Total Gains Per Share---1.5330.855-279%-1.083-29%0.133-1255%0.047-3388%
Usd Book Value--59488000.00049956750.000+19%51475250.000+16%56002400.000+6%52765100.000+13%
Usd Book Value Change Per Share---3.2830.417-887%-1.084-67%0.045-7371%0.003-115257%
Usd Book Value Per Share--8.9287.498+19%5.332+67%7.926+13%7.680+16%
Usd Dividend Per Share--1.7500.437+300%0.000+1313037%0.088+1899%0.044+3899%
Usd Eps---1.6600.745-323%-0.861-48%-0.988-41%-0.904-46%
Usd Free Cash Flow---11062000.000-13235750.000+20%-15482750.000+40%-7498700.000-32%-5869100.000-47%
Usd Free Cash Flow Per Share---1.660-1.986+20%-1.721+4%-1.005-39%-0.821-51%
Usd Free Cash Flow To Equity Per Share---3.410-2.424-29%-1.721-50%-0.136-96%0.386-984%
Usd Market Cap22202648.378-74%38645400.00032680182.675+18%19011400.864+103%21312047.128+81%21130039.484+83%
Usd Price Per Share3.332-74%5.8004.905+18%0.459+1162%2.720+113%2.932+98%
Usd Profit---11063000.0005199250.000-313%-12185500.000+10%-7824200.000-29%-6647075.000-40%
Usd Revenue---18162000.000-100%15247000.000-100%11103600.000-100%6234625.000-100%
Usd Total Gains Per Share---1.5330.855-279%-1.083-29%0.133-1255%0.047-3388%
 EOD+3 -5MRQTTM+20 -14YOY+21 -135Y+17 -1710Y+14 -20

4.2. Fundamental Score

Let's check the fundamental score of MEI Pharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.502
Price to Book Ratio (EOD)Between0-10.373
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than114.156
Current Ratio (MRQ)Greater than18.232
Debt to Asset Ratio (MRQ)Less than10.243
Debt to Equity Ratio (MRQ)Less than10.320
Return on Equity (MRQ)Greater than0.15-0.186
Return on Assets (MRQ)Greater than0.05-0.141
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of MEI Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.310
Ma 20Greater thanMa 503.634
Ma 50Greater thanMa 1003.921
Ma 100Greater thanMa 2004.765
OpenGreater thanClose3.330
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  32,289-26,8525,437-4,44499363,84564,838-64,923-85



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets78,538
Total Liabilities19,050
Total Stockholder Equity59,488
 As reported
Total Liabilities 19,050
Total Stockholder Equity+ 59,488
Total Assets = 78,538

Assets

Total Assets78,538
Total Current Assets66,172
Long-term Assets12,366
Total Current Assets
Cash And Cash Equivalents 5,174
Short-term Investments 54,306
Other Current Assets 6,692
Total Current Assets  (as reported)66,172
Total Current Assets  (calculated)66,172
+/-0
Long-term Assets
Property Plant Equipment 12,366
Long-term Assets  (as reported)12,366
Long-term Assets  (calculated)12,366
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,038
Long-term Liabilities11,012
Total Stockholder Equity59,488
Total Current Liabilities
Short-term Debt 1,015
Accounts payable 1,378
Other Current Liabilities 5,645
Total Current Liabilities  (as reported)8,038
Total Current Liabilities  (calculated)8,038
+/- 0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt11,012
Long-term Liabilities  (as reported)11,012
Long-term Liabilities  (calculated)11,012
+/- 0
Total Stockholder Equity
Retained Earnings -360,686
Other Stockholders Equity 420,174
Total Stockholder Equity (as reported)59,488
Total Stockholder Equity (calculated)59,488
+/-0
Other
Cash and Short Term Investments 59,480
Common Stock Shares Outstanding 6,663
Current Deferred Revenue0
Liabilities and Stockholders Equity 78,538
Net Debt 6,853
Net Invested Capital 59,488
Net Working Capital 58,134
Property Plant and Equipment Gross 13,572
Short Long Term Debt Total 12,027



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-30
> Total Assets 
9,185
0
0
0
7,286
6,567
32,368
25,560
24,849
23,836
23,126
20,501
19,364
18,582
17,785
13,324
10,395
20,958
20,299
18,352
16,290
29,031
26,633
23,198
19,978
25,054
23,306
23,306
19,356
12,859
11,451
9,136
9,136
7,618
7,618
5,211
4,168
4,943
5,222
3,293
6,373
4,355
27,584
24,947
36,547
32,617
61,155
56,043
49,808
42,917
79,738
71,598
64,750
59,068
55,016
50,931
47,164
61,045
58,210
59,891
55,704
48,031
43,567
37,397
104,657
94,750
96,305
85,926
82,663
68,923
107,105
96,623
209,728
214,009
203,880
186,122
174,098
176,351
209,464
194,429
177,840
163,583
147,599
134,187
120,809
101,251
78,538
78,538101,251120,809134,187147,599163,583177,840194,429209,464176,351174,098186,122203,880214,009209,72896,623107,10568,92382,66385,92696,30594,750104,65737,39743,56748,03155,70459,89158,21061,04547,16450,93155,01659,06864,75071,59879,73842,91749,80856,04361,15532,61736,54724,94727,5844,3556,3733,2935,2224,9434,1685,2117,6187,6189,1369,13611,45112,85919,35623,30623,30625,05419,97823,19826,63329,03116,29018,35220,29920,95810,39513,32417,78518,58219,36420,50123,12623,83624,84925,56032,3686,5677,2860009,185
   > Total Current Assets 
0
0
0
0
7,286
6,567
32,368
25,560
24,849
23,836
23,126
20,501
19,364
18,582
17,785
13,324
10,395
20,958
20,299
18,352
16,290
29,031
26,633
23,198
19,978
25,054
23,306
23,306
19,356
12,859
11,451
9,133
9,133
7,570
7,570
5,170
4,130
4,908
5,191
3,265
6,348
3,836
27,074
24,427
36,029
32,106
60,656
55,538
49,290
42,415
79,241
71,112
64,281
58,614
54,577
50,504
46,749
60,642
57,822
59,516
55,323
47,664
43,213
37,056
104,329
94,435
95,833
85,443
82,198
68,051
106,445
95,402
208,644
203,930
194,032
176,561
164,817
167,362
200,725
183,466
167,126
148,907
133,445
120,483
107,528
88,422
66,172
66,17288,422107,528120,483133,445148,907167,126183,466200,725167,362164,817176,561194,032203,930208,64495,402106,44568,05182,19885,44395,83394,435104,32937,05643,21347,66455,32359,51657,82260,64246,74950,50454,57758,61464,28171,11279,24142,41549,29055,53860,65632,10636,02924,42727,0743,8366,3483,2655,1914,9084,1305,1707,5707,5709,1339,13311,45112,85919,35623,30623,30625,05419,97823,19826,63329,03116,29018,35220,29920,95810,39513,32417,78518,58219,36420,50123,12623,83624,84925,56032,3686,5677,2860000
       Cash And Cash Equivalents 
9,164
0
0
0
7,244
6,375
32,304
25,546
24,819
23,782
23,106
20,231
9,238
8,422
17,735
12,863
10,054
20,894
20,226
18,271
16,158
28,927
26,571
22,902
19,743
24,989
23,152
23,152
19,067
12,814
11,341
9,031
9,031
7,479
7,479
4,851
3,858
4,800
4,991
2,722
6,202
3,713
26,877
24,167
35,573
31,504
39,762
19,670
13,777
17,041
23,657
20,465
18,722
17,876
13,674
14,291
10,837
13,789
15,050
11,644
8,458
6,958
7,339
6,198
13,309
6,118
8,748
7,426
9,590
5,984
8,638
7,438
12,331
10,956
9,877
9,745
8,543
15,621
12,551
11,112
15,740
14,653
10,917
8,812
16,906
3,372
5,174
5,1743,37216,9068,81210,91714,65315,74011,11212,55115,6218,5439,7459,87710,95612,3317,4388,6385,9849,5907,4268,7486,11813,3096,1987,3396,9588,45811,64415,05013,78910,83714,29113,67417,87618,72220,46523,65717,04113,77719,67039,76231,50435,57324,16726,8773,7136,2022,7224,9914,8003,8584,8517,4797,4799,0319,03111,34112,81419,06723,15223,15224,98919,74322,90226,57128,92716,15818,27120,22620,89410,05412,86317,7358,4229,23820,23123,10623,78224,81925,54632,3046,3757,2440009,164
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
10,000
10,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,001
35,007
35,016
25,021
55,051
50,055
45,057
40,142
40,116
35,111
35,081
45,112
40,104
45,116
45,107
40,065
35,102
30,004
89,434
84,646
84,667
74,864
64,899
59,932
95,243
85,360
170,299
165,179
170,267
154,879
144,883
129,882
173,200
157,930
137,512
123,714
113,256
103,224
83,787
78,830
54,306
54,30678,83083,787103,224113,256123,714137,512157,930173,200129,882144,883154,879170,267165,179170,29985,36095,24359,93264,89974,86484,66784,64689,43430,00435,10240,06545,10745,11640,10445,11235,08135,11140,11640,14245,05750,05555,05125,02135,01635,00720,0010000000000000000000000000000000010,00010,000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
457
530
530
5,274
469
481
512
20,420
20,420
10,606
7,432
7,582
18,120
10,151
8,446
10,044
7,758
5,704
4,580
85
0
0
00854,5805,7047,75810,0448,44610,15118,1207,5827,43210,60620,42020,4205124814695,27453053045700000000000000000000000000000000000000000000000000000000000000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-8,446
0
0
0
0
0
0
0
0000000-8,4460000000000000000000000000000000000000000000000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
48
48
41
38
35
31
28
25
519
510
520
518
511
499
505
518
502
497
486
469
454
439
427
415
403
388
375
381
367
354
341
328
315
472
483
465
872
660
1,221
1,084
10,079
9,848
9,561
9,281
8,989
8,739
10,963
10,714
14,676
14,154
13,704
13,281
12,829
12,366
12,36612,82913,28113,70414,15414,67610,71410,9638,7398,9899,2819,5619,84810,0791,0841,2216608724654834723153283413543673813753884034154274394544694864975025185054995115185205105192528313538414848330000000000000000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
48
48
41
38
35
31
28
25
23
22
41
48
50
46
61
83
75
79
77
68
62
56
53
49
46
40
35
50
45
40
36
32
28
193
213
204
619
416
986
1,084
10,079
9,848
9,561
9,281
8,989
8,739
10,963
10,714
14,676
14,154
13,704
13,281
12,829
12,366
12,36612,82913,28113,70414,15414,67610,71410,9638,7398,9899,2819,5619,84810,0791,084986416619204213193283236404550354046495356626877797583614650484122232528313538414848330000000000000000000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
496
488
479
470
461
453
444
435
427
418
409
401
392
383
374
366
357
348
340
331
322
314
305
296
287
279
270
261
253
244
235
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000023524425326127027928729630531432233134034835736637438339240140941842743544445346147047948849600000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
496
488
479
470
461
453
444
435
427
418
409
401
392
383
374
366
357
348
340
331
322
314
305
296
287
279
270
261
253
244
235
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000023524425326127027928729630531432233134034835736637438339240140941842743544445346147047948849600000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
496
488
479
470
461
453
444
435
427
418
409
401
392
383
374
366
357
348
340
331
322
314
305
296
287
0
0
0
0
0
0
0
0
0
0
0
0
14,974
0
0
0
0
0
0
0
0
0000000014,97400000000000028729630531432233134034835736637438339240140941842743544445346147047948849600000000000000000000000000000000000000000
> Total Liabilities 
286
0
0
0
1,353
1,729
6,697
1,417
1,907
2,124
2,789
1,904
2,843
3,864
4,845
3,636
1,260
1,194
2,714
2,533
2,513
3,444
3,365
3,262
3,443
2,537
2,668
2,668
4,143
1,487
2,292
1,755
1,755
1,876
1,876
1,865
2,374
1,588
1,296
1,499
1,774
1,630
1,797
1,782
1,675
1,465
2,428
3,518
4,616
5,308
6,882
6,638
4,959
3,127
3,378
4,025
5,512
18,714
3,320
4,989
4,866
4,465
5,209
4,484
54,198
54,991
42,835
48,044
34,733
21,643
29,820
22,125
131,510
131,681
130,382
141,160
132,736
144,524
132,214
126,623
125,427
126,275
99,225
99,833
96,185
19,890
19,050
19,05019,89096,18599,83399,225126,275125,427126,623132,214144,524132,736141,160130,382131,681131,51022,12529,82021,64334,73348,04442,83554,99154,1984,4845,2094,4654,8664,9893,32018,7145,5124,0253,3783,1274,9596,6386,8825,3084,6163,5182,4281,4651,6751,7821,7971,6301,7741,4991,2961,5882,3741,8651,8761,8761,7551,7552,2921,4874,1432,6682,6682,5373,4433,2623,3653,4442,5132,5332,7141,1941,2603,6364,8453,8642,8431,9042,7892,1241,9071,4176,6971,7291,353000286
   > Total Current Liabilities 
286
0
0
0
1,353
1,729
6,697
1,417
1,907
2,124
2,789
1,904
2,843
3,864
4,845
3,636
1,260
1,194
2,714
2,533
2,513
3,444
3,365
3,262
3,443
2,537
2,668
2,668
4,143
1,487
2,292
1,755
1,755
1,876
1,876
1,865
2,374
1,588
1,296
1,499
1,774
1,630
1,797
1,782
1,675
1,465
2,428
3,518
4,616
5,308
6,882
6,638
4,959
3,127
3,378
4,025
5,512
17,220
3,320
4,989
4,866
4,465
5,209
4,484
7,885
4,784
10,904
11,851
14,301
10,068
9,929
10,257
23,304
31,486
37,012
33,376
30,294
30,365
30,523
23,956
24,443
23,435
22,653
23,621
20,340
8,564
8,038
8,0388,56420,34023,62122,65323,43524,44323,95630,52330,36530,29433,37637,01231,48623,30410,2579,92910,06814,30111,85110,9044,7847,8854,4845,2094,4654,8664,9893,32017,2205,5124,0253,3783,1274,9596,6386,8825,3084,6163,5182,4281,4651,6751,7821,7971,6301,7741,4991,2961,5882,3741,8651,8761,8761,7551,7552,2921,4874,1432,6682,6682,5373,4433,2623,3653,4442,5132,5332,7141,1941,2603,6364,8453,8642,8431,9042,7892,1241,9071,4176,6971,7291,353000286
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
423
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
602
873
900
928
957
987
828
871
1,301
1,343
1,385
1,428
1,055
1,015
1,0151,0551,4281,3851,3431,301871828987957928900873602000000000000000000000000000000000004230000000000000000000000000000000000000
       Accounts payable 
198
0
0
0
433
453
926
140
192
86
212
253
254
334
278
140
420
187
805
860
1,197
1,226
870
1,066
1,130
690
1,112
1,112
736
635
760
830
830
765
765
698
328
331
381
441
594
533
448
528
537
557
809
700
1,708
1,111
2,152
2,711
863
253
448
466
1,079
749
382
242
585
751
1,089
1,259
3,643
1,555
2,158
1,969
4,787
3,098
3,038
2,492
2,437
6,375
5,555
5,571
6,355
8,472
6,256
8,257
7,918
8,418
4,067
4,389
6,134
3,220
1,378
1,3783,2206,1344,3894,0678,4187,9188,2576,2568,4726,3555,5715,5556,3752,4372,4923,0383,0984,7871,9692,1581,5553,6431,2591,0897515852423827491,0794664482538632,7112,1521,1111,7087008095575375284485335944413813313286987657658308307606357361,1121,1126901,1301,0668701,2261,19786080518742014027833425425321286192140926453433000198
       Other Current Liabilities 
88
0
0
0
920
1,276
5,771
1,277
1,715
2,038
2,577
1,651
2,589
3,530
4,567
3,496
840
1,007
1,909
1,673
1,316
2,218
2,495
2,196
2,313
1,847
1,556
1,556
3,407
852
1,532
925
925
1,111
1,111
1,167
2,046
1,257
915
1,058
1,180
1,097
1,349
1,254
1,138
908
1,619
2,818
2,908
4,197
4,730
3,927
4,096
2,874
2,930
3,559
4,433
2,428
2,938
3,711
3,285
2,767
3,230
2,382
3,454
2,489
4,766
5,685
4,559
3,295
3,835
5,287
6,090
5,537
11,102
7,762
8,402
6,099
9,765
10,082
10,820
9,216
14,346
16,264
12,461
4,289
5,645
5,6454,28912,46116,26414,3469,21610,82010,0829,7656,0998,4027,76211,1025,5376,0905,2873,8353,2954,5595,6854,7662,4893,4542,3823,2302,7673,2853,7112,9382,4284,4333,5592,9302,8744,0963,9274,7304,1972,9082,8181,6199081,1381,2541,3491,0971,1801,0589151,2572,0461,1671,1111,1119259251,5328523,4071,5561,5561,8472,3132,1962,4952,2181,3161,6731,9091,0078403,4964,5673,5302,5891,6512,5772,0381,7151,2775,7711,27692000088
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
802
0
1,453
0
1,689
1,869
1,552
1,884
1,904
1,592
1,362
3,186
930
852
1,011
925
837
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,494
0
0
0
0
0
0
46,313
50,207
31,931
36,193
20,432
11,575
19,891
11,868
108,206
100,195
93,370
107,784
102,442
114,159
101,691
102,667
100,984
102,840
76,572
76,212
75,845
11,326
11,012
11,01211,32675,84576,21276,572102,840100,984102,667101,691114,159102,442107,78493,370100,195108,20611,86819,89111,57520,43236,19331,93150,20746,3130000001,494000000000000000000000008379251,0118529303,1861,3621,5921,9041,8841,5521,8691,68901,453080200000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,494
0
0
0
0
0
0
46,313
50,207
31,931
36,193
20,432
11,575
19,891
11,868
108,206
92,123
85,528
100,176
95,072
107,044
94,836
93,456
92,213
90,459
64,545
0
64,545
0
0
0064,545064,54590,45992,21393,45694,836107,04495,072100,17685,52892,123108,20611,86819,89111,57520,43236,19331,93150,20746,3130000001,494000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,494
0
0
0
0
0
0
0
0
0
0
2,819
3,231
3,108
2,817
67,723
64,864
65,352
70,734
72,717
87,276
80,527
0
0
0
0
64,545
0
0
0
00064,545000080,52787,27672,71770,73465,35264,86467,7232,8173,1083,2312,81900000000001,494000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
8,899
0
0
0
5,933
4,838
25,671
24,143
22,942
21,712
20,337
18,597
16,521
14,718
12,940
9,688
9,135
19,764
17,585
15,819
13,777
25,587
23,268
19,936
16,535
22,517
20,638
20,638
15,213
11,372
9,159
7,381
7,381
5,742
5,742
3,346
1,794
3,355
3,926
1,794
4,599
2,725
25,787
23,165
34,872
31,152
58,727
52,525
45,192
37,609
72,856
64,960
59,791
55,941
51,638
46,906
41,652
42,331
54,890
54,902
50,838
43,566
38,358
32,913
50,459
39,759
53,470
37,882
47,930
47,280
77,285
74,498
78,218
82,328
73,498
44,962
41,362
31,827
77,250
67,806
52,413
37,308
48,374
34,354
24,624
81,361
59,488
59,48881,36124,62434,35448,37437,30852,41367,80677,25031,82741,36244,96273,49882,32878,21874,49877,28547,28047,93037,88253,47039,75950,45932,91338,35843,56650,83854,90254,89042,33141,65246,90651,63855,94159,79164,96072,85637,60945,19252,52558,72731,15234,87223,16525,7872,7254,5991,7943,9263,3551,7943,3465,7425,7427,3817,3819,15911,37215,21320,63820,63822,51716,53519,93623,26825,58713,77715,81917,58519,7649,1359,68812,94014,71816,52118,59720,33721,71222,94224,14325,6714,8385,9330008,899
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
78,436
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000078,4360000000000000000000000000000000000
   Retained Earnings Total Equity000-395,9680000-345,455-339,689-327,809-322,093-290,780-279,326-277,234-258,758-254,429-234,212-231,218-234,271-216,917-228,941-214,399-195,146-189,198-183,119-174,331-169,988-169,386-181,271-177,001-171,231-165,860-160,759-156,139-150,477-141,547-132,438-123,445-114,904-107,517-101,193-96,297-93,082-90,329-87,575-85,111-83,010-80,741-79,2000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
31
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-56
-56
0
0
-86
-86
0
0
-78
-78
0
0
-45
-45
0
0
-49
0
0
0
-94
0
0
-259,000
-62
-62
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000-62-62-259,00000-94000-4900-45-4500-78-7800-86-8600-56-5600000000000000000000000000000000000000000050310000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
82,555
84,667
84,804
89,710
90,300
116,116
116,247
131,169
132,345
166,244
167,429
168,637
170,047
214,403
215,437
215,930
216,700
217,498
218,137
218,653
223,602
224,276
224,890
225,169
226,685
227,556
228,059
264,858
268,700
270,387
272,153
279,148
281,492
331,714
333,256
355,452
361,654
364,278
367,055
369,171
371,516
422,705
0
0
0
0
430,322
0
0
0
000430,3220000422,705371,516369,171367,055364,278361,654355,452333,256331,714281,492279,148272,153270,387268,700264,858228,059227,556226,685225,169224,890224,276223,602218,653218,137217,498216,700215,930215,437214,403170,047168,637167,429166,244132,345131,169116,247116,11690,30089,71084,80484,66782,5550000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
9,058
9,058
34,623
34,636
34,636
34,636
34,636
34,636
34,636
34,636
34,636
34,636
34,636
53,145
53,141
53,098
53,098
68,274
68,266
68,266
68,266
78,099
78,124
78,124
78,124
78,124
78,124
78,188
78,188
78,308
78,308
79,292
79,382
82,555
84,667
84,804
89,710
90,300
116,116
116,247
131,169
132,345
166,244
167,429
168,693
170,047
214,403
215,437
216,016
216,700
217,498
218,137
218,731
223,602
224,276
224,890
225,214
226,685
227,556
228,059
264,907
268,700
270,387
272,153
279,242
281,492
331,714
592,256
355,514
361,654
364,278
367,055
369,171
371,516
422,705
425,902
426,572
428,091
428,904
430,322
430,621
430,984
420,174
420,174430,984430,621430,322428,904428,091426,572425,902422,705371,516369,171367,055364,278361,654355,514592,256331,714281,492279,242272,153270,387268,700264,907228,059227,556226,685225,214224,890224,276223,602218,731218,137217,498216,700216,016215,437214,403170,047168,693167,429166,244132,345131,169116,247116,11690,30089,71084,80484,66782,55579,38279,29278,30878,30878,18878,18878,12478,12478,12478,12478,12478,09968,26668,26668,26668,27453,09853,09853,14153,14534,63634,63634,63634,63634,63634,63634,63634,63634,63634,63634,6239,0589,0580000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue48,816
Cost of Revenue-1,815
Gross Profit47,00147,001
 
Operating Income (+$)
Gross Profit47,001
Operating Expense-85,580
Operating Income-36,764-38,579
 
Operating Expense (+$)
Research Development52,450
Selling General Administrative33,130
Selling And Marketing Expenses0
Operating Expense85,58085,580
 
Net Interest Income (+$)
Interest Income3,345
Interest Expense-0
Other Finance Cost-0
Net Interest Income3,345
 
Pretax Income (+$)
Operating Income-36,764
Net Interest Income3,345
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-31,838-38,345
EBIT - interestExpense = -38,367
-36,786
-31,838
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-38,367-31,838
Earnings Before Interest and Taxes (EBITDA)-37,981
 
After tax Income (+$)
Income Before Tax-31,838
Tax Provision-0
Net Income From Continuing Ops-31,838-31,838
Net Income-31,838
Net Income Applicable To Common Shares-31,838
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses85,580
Total Other Income/Expenses Net1,581-3,345
 

Technical Analysis of MEI Pharma Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of MEI Pharma Inc. The general trend of MEI Pharma Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine MEI Pharma Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MEI Pharma Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 3.3402033011272 < 3.4601 < 3.55.

The bearish price targets are: 3.2 > 3.1926149475525 > 3.1071428571429.

Tweet this
MEI Pharma Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MEI Pharma Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MEI Pharma Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MEI Pharma Inc. The current macd is -0.19863754.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the MEI Pharma Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for MEI Pharma Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the MEI Pharma Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
MEI Pharma Inc Daily Moving Average Convergence/Divergence (MACD) ChartMEI Pharma Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MEI Pharma Inc. The current adx is 28.89.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell MEI Pharma Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
MEI Pharma Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MEI Pharma Inc. The current sar is 3.83402861.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
MEI Pharma Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MEI Pharma Inc. The current rsi is 37.31. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
MEI Pharma Inc Daily Relative Strength Index (RSI) ChartMEI Pharma Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MEI Pharma Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the MEI Pharma Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
MEI Pharma Inc Daily Stochastic Oscillator ChartMEI Pharma Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MEI Pharma Inc. The current cci is -85.21443754.

MEI Pharma Inc Daily Commodity Channel Index (CCI) ChartMEI Pharma Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MEI Pharma Inc. The current cmo is -25.27159507.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
MEI Pharma Inc Daily Chande Momentum Oscillator (CMO) ChartMEI Pharma Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MEI Pharma Inc. The current willr is -84.61627907.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
MEI Pharma Inc Daily Williams %R ChartMEI Pharma Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MEI Pharma Inc.

MEI Pharma Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MEI Pharma Inc. The current atr is 0.21134984.

MEI Pharma Inc Daily Average True Range (ATR) ChartMEI Pharma Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MEI Pharma Inc. The current obv is 2,532,370.

MEI Pharma Inc Daily On-Balance Volume (OBV) ChartMEI Pharma Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MEI Pharma Inc. The current mfi is 27.44.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
MEI Pharma Inc Daily Money Flow Index (MFI) ChartMEI Pharma Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MEI Pharma Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

MEI Pharma Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MEI Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.310
Ma 20Greater thanMa 503.634
Ma 50Greater thanMa 1003.921
Ma 100Greater thanMa 2004.765
OpenGreater thanClose3.330
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of MEI Pharma Inc with someone you think should read this too:
  • Are you bullish or bearish on MEI Pharma Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about MEI Pharma Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MEI Pharma Inc

I send you an email if I find something interesting about MEI Pharma Inc.


Comments

How you think about this?

Leave a comment

Stay informed about MEI Pharma Inc.

Receive notifications about MEI Pharma Inc in your mailbox!